Knowledge about HIV infection and acceptability of HIV testing among women delivered in Podkarpackie Province, Poland

Raba, Grzegorz; Skręt-Magierło, Joanna

doi:10.1016/j.ijgo.2009.08.024

Cited by 4 publications

(6 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The searches yielded 15 004 records after de‐duplication; after full‐text review, 368 studies were included in the overall systematic review (Figure ). Of the 368 studies, 130 are described in this paper, exploring interventions and feasibility of HIV testing in health care settings in Europe, including 84 peer‐reviewed articles and 46 conference proceedings (Table ) .…”

Section: Resultsmentioning

confidence: 99%

“…Most studies were from Northern Europe ( n = 78; 64%), followed by Western ( n = 23) and Southern Europe ( n = 24). There was only one study from Eastern Europe and four studies set across multiple European countries . The majority of the studies from Northern Europe were from the UK (92%).…”

Section: Resultsmentioning

confidence: 99%

“…Routine testing was most commonly implemented in hospital departments including emergency departments (n = 15) [20,21,25,35,36,64,69,78,92,93,[115][116][117]137,147], inpatient units (n = 10) [24,43,61,95,98,104,111,125,130,135] and outpatient departments (n = 4) [21,74,113,116]. Similarly, IC testing programmes were predominantly instigated in hospitals (n = 8) [109,114,116,[125][126][127][128]135] and primary care (n = 10) [26,38,47,57,88,110,114,116,127,128]. In contrast, integrated testing for HIV with other infections such as hepatitis B and C and STIs was adopted in diverse settings including prisons (n = 3)…”

Section: Testing Provision Strategiesmentioning

confidence: 99%

See 2 more Smart Citations

HIV testing strategies employed in health care settings in the European Union/European Economic Area (EU/EEA): evidence from a systematic review

et al. 2019

View full text Add to dashboard Cite

Objectives Despite the availability of HIV testing guidelines to facilitate prompt diagnosis, late HIV diagnosis remains high across Europe. The study synthesizes recent evidence on HIV testing strategies adopted in health care settings in the European Union/European Economic Area (EU/EEA). Methods Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) guidelines were followed and systematic searches were run in five databases (2010–2017) to identify studies describing HIV testing interventions in health care settings in the EU/EEA. The grey literature was searched for unpublished studies (2014–2017). Two reviewers independently performed study selection, data extraction and critical appraisal. Results One hundred and thirty intervention and/or feasibility studies on HIV testing in health care settings were identified. Interventions included testing provision (n = 94), campaigns (n = 14) and education and training for staff and patients (n = 20). HIV test coverage achieved through testing provision varied: 2.9–94% in primary care compared to 3.9–66% in emergency departments. HIV test positivity was lower in emergency departments (0–1.3%) and antenatal services (0–0.05%) than in other hospital departments (e.g. inpatients: 0–5.3%). Indicator condition testing programmes increased HIV test coverage from 3.9–72% before to 12–85% after their implementation, with most studies reporting a 10–20% increase. There were 51 feasibility and/or acceptability studies that demonstrated that HIV testing interventions were generally acceptable to patients and providers in health care settings (e.g. general practitioner testing acceptable: 77–93%). Conclusions This review has identified several strategies that could be adopted to achieve high HIV testing coverage across a variety of health care settings and populations in the EU/EEA. Very few studies compared the intervention under investigation to a baseline, but, where this was assessed, data suggested increases in testing.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Testing Provision Strategiesmentioning

confidence: 99%

See 1 more Smart Citation

HIV testing strategies employed in health care settings in the European Union/European Economic Area (EU/EEA): evidence from a systematic review

et al. 2019

View full text Add to dashboard Cite

show abstract

“…Dube and Nkosi [43] found that half of the women in their study felt 50% of respondents expressed willingness to be tested in a Chinese study by Li et al [36] and in an Ethiopian study by Moges and Amberbir [37] ; in contrast, other studies reported higher willingness to be tested (more than 75% of respondents expressed willingness to be tested) [38][39][40] . Some African studies demonstrated significant gaps between the willingness of pregnant women to receive HIV testing and their actual testing rates, as in studies from Sudan [41] and Tanzania [42] .…”

Section: Fear Of the Test Resultsmentioning

confidence: 94%

“…Most reviewed studies demonstrate that women's willingness to be tested for HIV during pregnancy was influenced by their knowledge about HIV/AIDS and MTCT [36,37,39,41,58,60,[72][73][74] . Other studies found that knowledge was not related to willingness to be tested.…”

Section: Knowledge Perceived Susceptibility To Hiv and Perceived Bementioning

confidence: 99%

Women’s willingness to be tested for human immunodeficiency virus during pregnancy: A review

Ben-Natan

Hazanov

2015

WJV

View full text Add to dashboard Cite

not receive prevention services. HIV testing of pregnant women is considered to be one of the key strategies for preventing mother-to-child-transmission of HIV, but HIV testing rates among pregnant women in various countries remain suboptimal. Understanding the factors relating to women's willingness to be tested for HIV during pregnancy is critical for developing strategies to increase HIV testing rates among pregnant women. Extensive research points to various factors relating to women's willingness to be tested for HIV during pregnancy, and various recommendations aimed at improving testing rates among pregnant women have been suggested based on the research. In light of the goals set by the United Nations to reduce the rate of infants infected with HIV, it is necessary to summarize what is currently known regarding factors related to women's willingness to be tested for HIV during pregnancy. The purpose of this review is therefore to examine factors related to women's willingness to be tested for HIV during pregnancy, and to summarize recommendations for practice and further research. Core tip: The willingness of women to be tested for human immunodeficiency virus (HIV) during pregnancy is a complex phenomenon. There is frequent inconsistence in research results; however, studies have shown that certain major factors are steadily identified over time as associated with the phenomenon. Numerous factors related to pregnant women's willingness to be tested suggest multiple possible interventions to maximize HIV testing efficiency and increase testing rates. There is a need in further research of the phenomenon, as the majority of the research literature focuses on sub-Saharan Africa.Women's willingness to be tested for human immunodeficiency virus during pregnancy: A review Ben-Natan M, Hazanov Y. Women's willingness to be tested for human immunodeficiency virus during pregnancy: A review.

show abstract

HIV Voluntary Testing among Portuguese Women Attending Family Planning Clinics: Implications for HIV Prevention Education and Testing

Costa

Oliveira

Pereira

2015

International Journal of Sexual Health

View full text Add to dashboard Cite

Knowledge about HIV infection and acceptability of HIV testing among women delivered in Podkarpackie Province, Poland

Abstract: These pregnant women from Poland, where prenatal HIV testing is rarely done, showed a limited knowledge of perinatal HIV transmission but a high willingness to undergo HIV testing.

Cited by 4 publications

References 12 publications

HIV testing strategies employed in health care settings in the European Union/European Economic Area (EU/EEA): evidence from a systematic review

HIV testing strategies employed in health care settings in the European Union/European Economic Area (EU/EEA): evidence from a systematic review

Women’s willingness to be tested for human immunodeficiency virus during pregnancy: A review

HIV Voluntary Testing among Portuguese Women Attending Family Planning Clinics: Implications for HIV Prevention Education and Testing

Contact Info

Product

Resources

About